# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Sotera Health (NASDAQ:SHC) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.12 by...
Barclays analyst Luke Sergott maintains Sotera Health (NASDAQ:SHC) with a Overweight and lowers the price target from $19 to...
Citigroup analyst Patrick Donnelly upgrades Sotera Health (NASDAQ:SHC) from Neutral to Buy and lowers the price target from ...
Jefferies analyst David Windley upgrades Sotera Health (NASDAQ:SHC) from Hold to Buy and raises the price target from $15 to...
Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it con...